The 4th International Electronic Conference on Brain Sciences
Part of the International Electronic Conference on Brain Sciences series
23–25 Oct 2024
Neurorehabilitation, Neuroscience, Cognition, Neurodegenerative Diseases, Neurotechnology, Neuroimaging
- Go to the Sessions
- Event Details
-
- IECBS 2024 Conference Closed!
- Welcome from the Chair
- Program Overview
- IECBS 2024 Program (DAY1)
- IECBS 2024 Program (DAY2)
- IECBS 2024 Program (DAY3)
- Book of Abstracts
- Event Chair
- Event Speakers
- Sessions
- Registration
- Instructions for Authors
- Publication Opportunity
- List of Accepted Submissions
- Event Awards
- Sponsors and Partners
- Poster Gallery
- Conference Secretariat
- Events in series IECBS
IECBS 2024 Conference Closed!
On behalf of the conference organizing committee, we would like to express our appreciation to all the participants for your invaluable contributions to the 4th International Electronic Conference on Brain Sciences (IECBS 2024). We are genuinely thrilled with the diverse and engaged scholars who shared their knowledge and showcased impactful research. Your dedication has been instrumental in the great success of this conference!
Live session recording will be uploaded soon.
The poster gallery is available here.
Participants in this conference are cordially invited to contribute a full manuscript to the Special Issue published in Brain Sciences (ISSN: 2076-3425, IF 2.7), with a 20% discount on the publication fee. Special Issue information: "Selected Papers from the 4th International Electronic Conference on Brain Sciences" (https://www.mdpi.com/journal/brainsci/special_issues/1J47XZ11CO). All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
Please note if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers.
All accepted abstracts will be published in the conference report of The 4th International Electronic Conference on Brain Sciences in the Biology and Life Sciences Forum (ISSN: 2673-9976), if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference. Publication of the proceedings will be free of charge. Authors are asked to disclose that it is a proceeding paper of the IECBS 2024 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings paper submission deadline: 11 December 2024.
More Info: https://sciforum.net/event/iecbs2024#?section=#Publication_Opportunity
Welcome from the Chair
Dear colleagues,
It is our pleasure to invite you to join the 4th International Electronic Conference on Brain Sciences (IECBS 2024) after the strong success of the previous annual online conference. IECBS 2024 will be held online from 23 to 25 October 2024.
The field of neuroscience is one of the most important frontiers in biomedical studies, as many of the details that control brain function are still not well understood. This makes the study of the nervous system very exciting and fast moving. This conference will address a variety of research topics which reflect some of the current areas of focus. Topics of the conference will be organized around the following sessions:
S1. Behavioral Neuroscience
S2. Systems Neuroscience
S3. Neurotechnology and Neuroimaging
S4. Neuropsychology
S5. Neurodegenerative Diseases
S6. Cognitive Neuroscience
S7. Clinical Neuroscience
S8. Molecular and Cellular Neuroscience
S9. Neurorehabilitation
The scope of this online conference is to bring together well-known worldwide experts who are currently working on brain sciences and to provide an online forum for presenting and discussing new results.
All accepted abstracts will be published on the conference website. You are required to submit an abstract (200 – 250 words). Please see the abstract guidelines in "Instructions for Authors".
On behalf of the Organizing Committee, we cordially invite you to join us at the 4th International Electronic Conference on Brain Sciences (IECBS 2024).
We look forward to your contributions.
Sincerely,
Prof. Dr. Stephen D. Meriney
Chair of the 4th International Electronic Conference on Brain Sciences
Program Overview
23rd Morning | 24th Morning | 25th Morning |
Session 5. Neurodegenerative Diseases Session 3. Neurotechnology and Neuroimaging |
Session 1. Behavioral Neuroscience | |
23rd Afternoon | 24th Afternoon | 25th Afternoon |
Session 4. Neuropsychology Session 9. Neurorehabilitation |
Session 7. Clinical Neuroscience Session 8. Molecular and Cellular Neuroscience |
Session 6. Cognitive Neuroscience Session 2. Systems Neuroscience |
IECBS 2024 Program (DAY1)
IECBS 2024
Session 5. Neurodegenerative Diseases
Session 3. Neurotechnology and Neuroimaging
Date: 23rd October 2024 (Wednesday)
Time: 9:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
Time in CEST | Speaker | Title |
09:00-09:10 | Assoc. Prof. Carla Masala Session Chair |
Welcome from the Session Chair |
09:10-09:30 | Prof. Paolo Solla Invited Speaker |
Olfactory Impairment as predictor of REM Sleep Behavior Disorder (RBD) in Parkinson's Disease |
09:30-09:45 |
Kadir Uludag |
Virtual Reality for Schizophrenia Symptom Regulation |
09:45-10:00 | Iasmina Honceriu | Anti-Dementia Effects of Mansorin A, Mansonone G, and 6-Paradol in the Okadaic Acid-Induced Zebrafish Model of Alzheimer's Disease |
10:00-10:15 | Ephraim Chidi Ezeigbo | Distinct Huntington's aggregates differently impact viability and motility of C. elegans; Atomic force Microscopy |
10:15-10:25 | Dr. Sarah C. Hellewell Live Session Chair |
Welcome from the Live Session Chair |
10:25-10:45 |
Prof. Vincent P. Clark |
Brain Stimulation Guided by Neuroimaging to Improve Memory |
10:45-11:00 |
Dr. Moses O. Sokunbi |
Speech Generation using BCI |
11:00-11:15 |
Vincenzo Ronca |
Simulation study on novel processing algorithms for ocular artifacts’ detection and correction from electroencephalographic techniques |
11:15-11:30 |
Vsevolod Lyakhovetskii |
Methods for estimating the similarity of contours of gray matter in mammalian spinal cord transverse sections |
IECBS 2024
Session 4. Neuropsychology
Session 9. Neurorehabilitation
Date: 23rd October 2024 (Wednesday)
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
Time in CEST | Speaker | Title |
14:00-14:10 | Prof. Dr. Pierluigi Zoccolotti Session Chair |
Welcome from the Session Chair |
14:10-14:40 | Prof. Audrey Bowen Keynote Speaker |
Can consensus methods help build an evidence-based clinical pathway for identifying and managing spatial neglect? |
14:40-15:10 | Dr. Peii Chen Keynote Speaker |
Current approaches to treat spatial neglect |
15:10-15:40 |
Prof. Dr. Pierluigi Zoccolotti Keynote Speaker |
Open and emerging issues on spatial neglect |
15:40-15:55 | Juan Fraile Ramos | Addressing education inequality to combat dementia in Sub-Saharan Africa: Nigerian women in the eye of the storm. |
15:55-16:10 |
Francesca Conca | Mapping the effect of psycholinguistic variables on picture naming: insights from an FDG-PET study on neurodegenerative diseases |
16:10-16:20 | Dr. Christina Danielli Coelho De Morais Faria Session Chair |
Welcome from the Session Chair |
16:20-16:40 | Professor Sylvie Nadeau & Professor Dahlia Kairy Invited Speakers |
Program ENSEMBLE!- Training with innovative technologies based on rehabilitation research: challenges and opportunities for patients, clinicians and researchers |
16:40-17:00 | Professor Alessandra Swarowsky Invited Speaker |
Challenges for implementing the Parkinson’s disease clinical practice guideline |
17:00-17:15 | Paula da Cruz Peniche | Predictors of adopting healthy lifestyle behaviors: a cross-sectional study to target secondary stroke prevention in a middle-income country |
17:15-17:30 | Siddhi Sunil Tamanekar | "Dual Task Neglect System: AR-Gamified Assessment and Rehabilitation Application for Hemispatial Neglect" |
17:30-17:45 | Jordana de Paula Magalhães | Immediate effects and perceptions of cane use in individuals with Parkinson's Disease |
IECBS 2024 Program (DAY2)
IECBS 2024
Session 1. Behavioral Neuroscience
Date: 24th October 2024 (Thursday)
Time: 9:00 (CEST, Basel) | 03:00 (EDT, New York) | 15:00 (CST Asia, Beijing)
Time in CEST | Speaker | Title |
09:00-09:10 |
Dr. Lalitha Kurada |
Welcome from the Live Session Chair |
09:10-09:25 | Romina Fucà | Deciphering the Spatial Location of Paintings in the ‘Kunsthaus Hamburg’: An Algorithmic and Philosophical Exploration Using Blurred Images |
09:25-09:40 | Evgeniy Machnev | Error Monitoring in an Ecologically Valid Context: Exploring Event-Related Potentials |
09:40-09:55 | Archange Michel Emmanuel MBOUNGOU MALONGA | Prototype behavioural test of memory in Wistar rats exposed to valproic acid: AME Memoriavers maze |
09:55-10:10 | Ebrahim Ismaiel | Inter-brain synchronization during nonverbal social interactions: Mini-Systematic review of the last six years 2019-2024 |
IECBS 2024
Session 7. Clinical Neuroscience
Session 8. Molecular and Cellular Neuroscience
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
14:00-14:10 | Dr. Robert Emmett Kelly & Dr. Dejan B. Budimirovic Session Chairs |
Welcome from the Session Chairs |
14:10-14:40 | Dr. Tracy Butler Keynote Speaker |
Lewy Body Dementia, with a focus on a very useful new diagnostic technique that involves a non-invasive skin test |
14:40-14:55 | Fairuz Jayyusi | The Efficacy of Medical Interventions for Free-Floating Thrombus in Cerebrovascular Events: A Systematic Review |
14:55-15:05 |
Prof. Dr. Patricia A. Broderick & Dr. Stefano Casalotti |
Welcome from the Session Chairs |
15:05-15:35 | Prof. Dr. Patricia A. Broderick Keynote Speaker |
Amyloidosis is a neurodegenerative disease: Neuromolecular Imaging the Tau Peptide LIVE with a Quantum Polymer Sensing System based on the Broderick Nanoprobe: Parkinson’s Disorders and the epilepsies |
15:35-15:50 | Shraddha Tripathi | LncRNA JINR1 regulates neuronal cell death and flavivirus replication by regulating the miR-216b-5p target gene. |
15:50-16:05 | Wafaa TAHA | The correlation between prenatal depression, inflammation, and gut microbiota: an integrative analysis |
16:05-16:20 | Agbonlahor Okhuarobo | Inhibition of CYP2D enzyme in the brain reduces oral oxycodone induced conditioned place preference in rats |
16:20-16:35 | Karina Gilizhdinova | 24-hydroxycholesterol prevents pronociceptive effects of ATP in the rat trigeminovascular system |
IECBS 2024 Program (DAY3)
IECBS 2024
Session 6. Cognitive Neuroscience
Session 2. Systems Neuroscience
Date: 25th October 2024 (Friday)
Time: 14:00 (CEST, Basel) | 08:00 (EDT, New York) | 20:00 (CST Asia, Beijing)
Time in CEST | Speaker | Title |
14:00-14:10 | Prof. Dr. Gerry Leisman Session Chair |
Welcome from the Session Chair |
14:10-14:40 | Prof. Dr. Gerry Leisman Keynote Speaker |
Living the Inverted “U”: Connecting Ups and Downs from Fetus to Grave in Movement and Cognition |
14:40-14:55 |
Francesca Conca |
The precuneus is tuned to words that refer to time, not to space, whereas the IPS has no preferences |
14:55-15:10 |
Alberto Zani | A Functional Neuroimaging Study on the Sensitivity of Decision Making and Mental Workload to Hypoxia |
15:10 – 15:20 | Prof. Dr. Konstantin V. Slavin Session Chair |
Welcome from the Session Chair |
15:20 – 15:35 |
Chitaranjan Mahapatra |
A mathematical model to study the stochastic synaptic noise dynamics in subthalamic neuron electrophysiology concerning Parkinson's disease |
15:35 – 15:50 | Jinsung Wang | The effects of different types of unlearning on savings following visuomotor adaptation |
15:50 – 16:05 | Jose Joaquin Merino | Maraviroc, a CCR5 chemokine blocker, enhanced corticosterone release in a postraumatic stress disorder model in rats: effects of chronic stress and fear on hippocampal CCR5/RANTES axis. |
Book of Abstracts
Event Chair
Stephen D. Meriney completed his PhD in Physiology/Neuroscience at the University of Connecticut with Dr. Guillermo Pilar in 1986, where he studied the parasympathetic control of intrinsic eye muscles. He then moved to the Jerry Lewis Neuromuscular Research Centre at the University of California, Los Angeles (UCLA) as a postdoctoral fellow, and then became an assistant research physiologist there, with Dr. Alan Grinnell, and studied voltage-gated calcium channels and synaptic mechanisms at the neuromuscular junction. He has been at the University of Pittsburgh since 1993, where he is currently a Professor, and Chair of the Department of Neuroscience, with a secondary appointment in the Department of Psychiatry at the University of Pittsburgh Medical Center. He is currently Editor-in-Chief of the journal Brain Sciences.
Session Chairs
Dr. Christina Danielli Coelho De Morais Faria
Department of Physical Therapy, Universidade Federal de Minas Gerais, Brazil
neurorehabilitation; disability; stroke; Parkinson disease; movement disorders; physical therapy; clinical trials; systematic review; meta-analysis; methodological studies
Professor Christina Danielli Coelho de Morais Faria is an Associate Professor of the Physical Therapy Department at Federal University ot Minas Gerais (Universidade Federal de Minas Gerais / UFMG), Brazil. She is a lecturer and researcher with 19 years of experience teaching courses at both undergraduate and postgraduate levels in the neurorehabilitation field. Before joining UFMG in 2010, she held a doctoral fellowship to carry out part of her research project at Université de Montréal (Canada) in neurorehabilitation, and, therefore, part of her Ph.D. was done at this university (from June 2007 to July 2008). Since 2016 she has received a fellowship as senior researcher and since 2020 she has been the leader of a research group in adult neurorehabilitation in Brazil. She is a member of the editorial board of the Disability and Rehabilitation Journal, Brazilian Journal of Physical Therapy, and Brain Sciences. From 2021 to 2023 she was the head of the Physical Therapy Department at UFMG, Brazil. She did her postdoc at University College Dublin (Ireland) from November 2023 to March 2024, with the financial support of the Worldwide University Network (WUN).
Dr. Evanthia Bernitsas
Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, MI 48201, USA
demyelinating disorders; clinical trials; therapeutic neuroimaging; OCT
-
Prof. Dr. Gerry Leisman
Movement and Cognition Laboratory, Faculty of Social Welfare and Health Sciences Haifa University, Haifa, Israel, Department of Clinical Neurophysiology, Institute for Neurology and Neurosurgery, University of the Medical Sciences of Havana, Havana, Cuba
developmental neuroscience; computational neuroscience; cognitive neuroscience; fetal cognition; neuroplasticity; consciousness; neuroeducation hunter
Gerry Leisman is an Israeli neuroscientist who studies complex systems theory and developmental cognitive neuroscience in the fetus, newborn, and developing child. He has published significantly on developmental aspects of brain plasticity, neurorehabilitation, and dynamic brain networks. His work has linked physics, mathematics, and other disciplines to better understand developmental brain function and malfunction, advancing theoretical frameworks, and practical applications in Medicine, Psychology, and Education. He studied in the Faculty of Medicine at Manchester University, additionally earning a Ph.D. in Neuroscience and Biomedical Engineering from Union University in 1979. He is a Full Professor and Research Fellow at the University of Haifa’s Movement and Cognition laboratory and a Professor of Neurology at the University of the Medical Sciences, Resonance Therapeutics Laboratory at the Institute for Neurology and Neurosurgery in Havana Cuba.
Dr. Robert Emmett Kelly
Clinical Psychiatry, Weill Cornell Medical College, White Plains, NY 10605, USA
adult psychiatry; geriatric psychiatry; mood disorders; brain fMRI; brain functional connectivity; visual inspection of independent components; dual regression
Dr. Robert Kelly is a Clinical Associate Professor of Psychiatry at Weill Cornell Medical College, who works as a psychiatrist at New York-Presbyterian Hospital. His clinical subspecialty training is in Geriatric Psychiatry and NIH-sponsored research fellowship training in neuroimaging and geriatric mood disorders. His research work focuses on research methods, particularly as they pertain to neuroimaging. More broadly, his work addresses medical research with a focus on replicability of results, the interpretation of existing research results, and the total costs required to reliably confirm research hypotheses. The recent search for a cure for COVID-19 is an example where such considerations became highly relevant. He has served as Cornell site principal investigator for the International Study to Predict Optimized Treatment for Depression and served the American Psychiatric Association on committees, including serving as Chair of the Elections Committee, where he played an instrumental role in rewriting the APA Election Guidelines, which are a set of rules to promote collegial and informative discussions among candidates who compete for APA leadership roles. Today he will give a brief talk on the subject of relevant biomarkers for clinical neuroscience applications, and introduce our keynote speaker.
Dr. med. Dejan B. Budimirovic
Department of Psychiatry, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD 21205, USA, Department of Psychiatry & Behavioral Sciences-Child Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
fragile X syndrome; clinical trials; targeted treatments; autism; autism spectrum disorder; fragile X premutation; fragile X-associated disorders
Dejan Budimirovic, M.D., (pronounced Day-ahn Boo-dee-meer-o-vich) is a nationally and internationally recognized developmental neuropsychiatrist and expert on neurodevelopmental disorders (NDDs). His expertise is in fragile X-associated disorders (FXD) across all ages, including FMR1 gene full-mutation, clinical fragile X syndrome (FXS)†, and the pre-mutation-linked fragile X-associated neuropsychiatric disorders‡.Through his impactful clinical, research, and educational efforts, Dr Budimirovic has also delivered a sustained therapeutic benefit for many of his patients with autism spectrum disorder (ASD) and related disorders. Over the last 12 years, he has also provided an advanced ASD-related clinical educational experience for over 30 undergraduate pre-med students from Johns Hopkins University. With over 23,000 outpatient visits during the previous 20 years and over 70 ongoing and past clinical studies as the main sub- and principal investigator of cutting-edge clinical trial modalities, respectively, at the Kennedy Krieger Institute over the last 12 years, he has also demonstrated expertise in diagnosis, evaluation, and management of ADHD, major depression, bipolar, and anxiety and other psychiatric disorders with and without FXD or/and ASD.
Prof. Dr. Patricia A. Broderick
1. Department of Molecular, Cellular and Biomedical Sciences, CUNY School of Medicine, The City College of New York, New York, NY 10031, USA 2. Adjunct Professor in Neurology, NYU Langone Medical Center & Comprehensive Epilepsy Center, New York, NY 10016, USA
biosensors; chemical sensors; nanosensors; bioprobes; neuromolecular imaging (NMI); neurotransmitters; neurochemicals; in vitro; in vivo; in situ; brain; behavior; neurosystem disorders and treatment
Dr. Prof. Patricia A. Broderick PhD is a Full and Tenured Medical Professor in the Department of Molecular and Cellular Science at the City University of New York Medical School, CCNY, USA. Patricia serves as CUNY Graduate Faculty in Psychology and Biology. Patricia earned her doctoral degree in Pharmacology at the St. John’s University College of Arts and Sciences where she discovered that the neurotransmitter, serotonin, has an active role in the neuronal balance of lithium therapy for bipolar illness. Patricia was then recruited by the Albert Einstein College of Medicine, Depts. Psychiatry and Neuroscience to serve as Postdoctoral Fellow and with her expertise in atomic absorption spectrophotometry and fluorescence spectroscopy, Patricia wedded behavior directly to the brain electronically and invented the BRODERICK PROBE® nanoprobe biosensor which bears her father’s name. Einstein was the first to patent her work! The work continued at Cornell Medical Center, upstate, focusing on cognition and hypoxia as Research Fellow. Then, her innovative brain/sensing research was recruited by the NYU Medical Center, Dept. Neurology and Comprehensive Epilepsy Center and Patricia was appointed as Adjunct Professor while continuing her CUNY Medical School work in tandem. Intraoperative studies of the epilepsy patient, under Institutional Review Board, approval, translated Patricia’s work to the clinic! The Dept. of Anesthesiology recruited Patricia to see inside the brain to heal postoperative memory loss. She founded the Broderick Brain Foundation and Eazysense Nanotechnologies Inc. which hold considerably valued Patents and Trademarks. Multiple editorial boards, podcasts and prolific publications are available. No stranger to the airways, Patricia serves public health as educator in the brain and electronic sciences every day. YouTube: Eazysense Nanotechnology.com@eazysense12345. Ready now, on the internet, is her new book Neuroimaging Sensing Biochemistry in the Brain. Jenny Stanford Publishing Pte. Ltd. Singapore
Dr. Stefano Casalotti
School of Health Sport and Bioscience, University of East London, London, UK
molecular neurobiology; alcohol addiction; drosophila models
Stefano Casalotti started his research career studying the structure of GABA receptors during his PhD at Imperial College London and Cambridge University, UK and of the , NMDA and peripheral Benzodiazepine receptors at Georgetown University, Washington DC during his postdoctoral fellowship. He started focusing on drug addiction during his lectureship at Mahidol University, Thailand studying gene expression changes in rodent brains stimulated with opiates and pseudoephedrine. He then worked at University College London studying molecular mechanisms of hearing focusing on gap junctions and opiate receptors. He then moved to the University of East London where he set up a Drosophila lab focused on studying the effect of alcohol on brain function. He is currently director of BiosearLab, a company focused on facilitating new collaborations between universities and external partners.
Prof. Dr. Konstantin V. Slavin
Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA
neuromodulation; facial pain; peripheral nerve stimulation; deep brain stimulation
-
Assoc. Prof. Carla Masala
Department of Biomedical Sciences, University of Cagliari, SP 8 Cittadella Universitaria, 09042 Monserrato, Italy
olfactory function; gustatory function; neurodegenerative diseases; cognitive function; COVID-19
Prof Carla Masala is an associate professor at the University of Cagliari, Department of Biomedical Sciences, Italy. Her research focused on olfactory and gustatory chemosensory physiology in humans and its role in human health, integrating methods of psychophysics and neurobiology. In particular, the study is focused on identifying the physiological bases of individual olfactory and gustatory variability in relation to sex, weight, age, cognitive abilities, depression, nutritional status, and human health. Research is currently focused on the role of olfactory dysfunction as a potential early biomarker in neurodegenerative diseases, autoimmune diseases and Long Covid syndrome. Previously, research activity of Prof. Masala has also concerned the physiology of the chemosensory system in experimental models with evolutionarily conserved functional mechanisms, such as insects, to analyse the processes of sensory transduction and coding
Assoc. Prof. Dr. Woon-Man Kung
1. Division of Neurosurgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23412, Taiwan; 2. Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, Taipei 11114, Taiwan
neurobiology; neurophysiology; neuropharmacology; neuroimaging; cognitive neuroscience; behavioral neurology; neuroinformatics
-
Prof. Dr. Pierluigi Zoccolotti
Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy
learning disorders; dyslexia and related disorders; models of dyslexia; eye movements in reading; space disorders of space and attention after traumatic brain damage; forms of hemi-neglect; rehabilitation of neglect disorders.
Pierluigi Zoccolotti has been a full professor of General Psychology in the Department of Psychology of Sapienza University of Rome. He taught Psychology of Learning Disabilities in the “Cognitive Neurosciences and Psychological Rehabilitation” international graduate program and participated in the PhD program in “Behavioral Neurosciences” and the post-graduate School of Specialization in “Neuropsychology”. He founded and coordinated the post-graduate master’s program in “Disturbances of learning and cognitive development”. He is currently an Emeritus professor at Sapienza University. Across the years, research interests spanned various areas of cognitive psychology and experimental and clinical neuropsychology, including studies on human lateralization, visuospatial neglect, and attentional disturbances in patients with vascular etiology, traumatic brain lesions or Alzheimer’s disease. He also worked to develop cognitive rehabilitation programs for spatial neglect and hemianopia. Since the late 90’s his research has encompassed developmental reading and spelling deficits. This theme was examined in studies ranging from perception to eye movements and psycholinguistic analysis. As part of this interest, he also developed various test materials and rehabilitation pieces of training for these disorders.
Event Committee
Leicester School of Allied Health Sciences, Faculty of Health and Life Sciences, De Montfort University, Leicester LE1 9BH, England, United Kingdom
Neural Engineering; Medical Imaging; Biomedical Signal Processing; Brain-Computer Interfaces; functional MRI; Entropy; Biomedical engineering
HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, 28938, Spain.
www.linkedin.com/in/tiziano-balzano-2935552a8
Neuroimmunology; Parkinson's disease; Neurovascular unit; Blood brain barrier; Glial cells; Neurodegenerative diseases.
Department of Life and Health Sciences, and Health Professions, Link Campus University, Via del Casale di S. Pio V, 44, 00165, Rome, Italy
general psychology, experimental psychology, cognitive processes, cognition, attention, memory, automatic and controlled processes, ADHD, cognitive neuroscience
Division of Anatomy and Neurobiology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland
neurodegeneration; olfactory system; dementia; metabolic diseases; diabetes; stroke
Department of Psychology, University of Almeria, 04120, Almeria, Spain,
Research Center for Wellbeing and Social Inclusion, University of Almeria, 04120, Almeria, Spain
virtual reality; neurorehabilitation; motor system; neuropsychology; dementia; visual perception
Department of Human and Social Sciences, University of Bergamo, Bergamo, 24129, Italy
Neurodevelopmental disorders, dyslexia, attention, reading difficulties, attentional training, language impairment, behavioural longitudinal studies
TGen Integrated Microbiomics Center, Translational Genomics Research Institute (TGen North), part of City of Hope, Flagstaff, AZ 86005, USA
Microbiome, Brain-Gut axis, Brain-microbiome axis, biofilm, neurological disorders, cancer-microbiome
Azienda Ospedaliero-Universitaria Sassari, University of Sassari, Viale San Pietro, 07100, Sassari, Italy
Neurology; Parkinson’s Disease; Dystonia; Movement Disorders; Functional Neurological Disorders
Human Motor Behavior Lab (HuMBLab), Zilber College of Public Health, University of Wisconsin-Milwaukee, Milwaukee, 53201, USA.
Motor control, motor learning, adaptation, neuromotor disorder, aging
School of Nursing and Midwifery, Edith Cowan University, Perth, WA 6027, Australia,
School of Nursing and Midwifery, Trinity College, D02 T283, Dublin, Ireland
Geropsychology; neuropsychology; cognitive health; brain health; healthy ageing; cerebral small vessel disease; cerebrovascular disease
Department of Neuroregeneration, Institute of Experimental Medicine of the Czech Academy of Sciences, 142 20, Prague, Czech Republic
spinal cord injury; ischemia; stroke; neural stem cells; microRNA Picture
Curtin University and The Perron Institute for Neurological and Translational Research, Perth, Australia 6008
traumatic brain injury; concussion; neurotrauma; MRI; neuroimaging
Victoria University, Institute of Sustainable Industries and Liveable Cities, Melbourne, VIC 3011, Australia
Artificial intelligence (AI); Data mining; machine learning; Deep learning; biomedical signal processing; detection and prediction of neurological disorders using brain signal data (e.g. electroencephalogram (EEG) signal data)
systems neuroscience; mathematical modelling of local field potentials and EEG; neurovascular coupling; balance of synaptic excitation and inhibition
Faculty of Psychology, eCampus University, 22060 Novedrate, CO, Italy
cognitive functions; experimental and clinical studies of neurodegenerative diseases; neuropsychological assessment; neuropsychological rehabilitation
Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences, Medical University of Silesia in Katowice, 41–200 Sosnowiec, Jedności Str 10, Poland
genetic, biochemical and clinical risk factors for cerebrovascular diseases in children; arterial ischemic stroke; post-stroke consequences; epilepsy; headache; cerebral palsy; modern drug forms (liposomes, nanoparticles)
Department of Biomedical Sciences, School of Health Sciences, International Hellenic University, Thessaloniki, Greece
Alzheimer's Disease, Clinical Neurophysiology, Mild Cognitive Impairment, EEG, Neurosciences
Laboratory Experimental Neurophysiology, IRCCS San Raffaele Pisana, 00166 Rome, Italy
neurodegenerative disease; neuronal plasticity; molecular electrophysiology; neuroinflammation; movement disorders
Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
autism spectrum disorder (ASD); catatonia; movement disorders; neurobehavioral measurements; neurodevelopmental disabilities; neurodegenerative disorders; positron emission tomography (PET); rating scales; schizophrenia; signal processing
eCampus University, Via Isimbardi, 10, 22060 Novedrate, Italy
RMI; EEG; computational neurosciences; behavioral models
Henry Jackson Foundation for the advancement of Military Medicine, Armed Forces Radiobiology Research Institute, Uniformed Services University, Bethesda, MD 20889, USA
neurological disorders and diseases; deep brain stimulation; EEG; epilepsy & attention; cognitive neuroscience;learning and memory; gut-brain axis; behavioral neuroscience; animal models
Keynote Speakers
Movement and Cognition Laboratory, Faculty of Social Welfare and Health Sciences Haifa University, Haifa, Israel,
Department of Clinical Neurophysiology, Institute for Neurology and Neurosurgery, University of the Medical Sciences of Havana, Havana, Cuba
Living the Inverted “U”: Connecting Ups and Downs from Fetus to Grave in Movement and Cognition
Gerry Leisman is an Israeli neuroscientist who studies complex systems theory and developmental cognitive neuroscience in the fetus, newborn, and developing child. He has published significantly on developmental aspects of brain plasticity, neurorehabilitation, and dynamic brain networks. His work has linked physics, mathematics, and other disciplines to better understand developmental brain function and malfunction, advancing theoretical frameworks, and practical applications in Medicine, Psychology, and Education. He studied in the Faculty of Medicine at Manchester University, additionally earning a Ph.D. in Neuroscience and Biomedical Engineering from Union University in 1979. He is a Full Professor and Research Fellow at the University of Haifa’s Movement and Cognition laboratory and a Professor of Neurology at the University of the Medical Sciences, Resonance Therapeutics Laboratory at the Institute for Neurology and Neurosurgery in Havana Cuba.
developmental neuroscience; computational neuroscience; cognitive neuroscience; fetal cognition; neuroplasticity; consciousness; neuroeducation hunter
Manchester Centre for Health Psychology and Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK
Can consensus methods help build an evidence-based clinical pathway for identifying and managing spatial neglect?
Audrey Bowen is Professor of Neuropsychological Rehabilitation at the University of Manchester, UK. Her research interests are in developing the evidence base for neurorehabilitation, specialising in post-stroke cognitive and communication difficulties. A key strength of Audrey’s research is patient, carer and public involvement in research (PCPI). Audrey leads the cross-cutting, multidisciplinary theme ‘Neurorehabilitation and Living with Disability’ within the Geoffrey Jefferson Brain Research Centre, a collaboration between The Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester. https://orcid.org/0000-0003-4075-1215
Kessler Foundation, Center for Stroke Rehabilitation Research, 1199 Pleasant Valley Way, West Orange, New Jersey, 07052, USA,
Rutgers New Jersey Medical School Department of Physical Medicine and Rehabilitation, 183 South Orange Avenue, Suite F-1560, Newark, New Jersey, 07101, USA
Current approaches to treat spatial neglect
Peii Chen, PhD, is a Senior Research Scientist at Kessler Foundation’s Center for Stroke Rehabilitation Research, the Intellectual Property Liaison at Kessler Foundation, and a Research Associate Professor of Physical Medicine and Rehabilitation at Rutgers University’s New Jersey Medical School. Her work is focused on spatial neglect, its related disorders, and its impacts on the lives of individuals with spatial neglect. Dr. Chen is the lead developer of the Kessler Foundation Neglect Assessment Process (KF-NAP®), Prism Adaptation Treatment (KF-PAT®), Spatial Re-training Therapy (KF-SRT®), Eye Movement Exercise (KF-EME™), and the 3s Spreadsheet Test. In addition to research and development activities, Dr. Chen advocates meaningful and effective knowledge translation via professional training and technology transfer to improve spatial neglect care.
Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy
Open and emerging issues on spatial neglect
learning disabilities; dyslexia and related disorders; models of dyslexia; eye movements in reading; language
Department of Radiology, Weill Cornell Medicine, New York, NY 10065, USA
Lewy Body Dementia, with a focus on a very useful new diagnostic technique that involves a non-invasive skin test
Dr. Tracy Butler is a neurologist and neuroscientist with clinical subspecialty training in behavioral neurology and epilepsy and research fellowship training in functional and structural neuroimaging. An Associate Professor of Neurology in Radiology at Weill Cornell Medical College, she is the medical director of Weill Cornell Medicine’s Brain Health Imaging Institute (BHII), where she oversees subject assessment and clinical trials of therapies and neuroimage biomarkers of aging and neurodegeneration. Her research uses multimodal positron emission tomography (PET) and magnetic resonance imaging (MRI) neuroimaging and complementary methods to better understand the biological basis of neuropsychiatric disorders including Alzheimer’s disease, traumatic brain injury, and normal aging, focusing on pathophysiologic overlap among these conditions such as hormonal dysregulation, neuroinflammation and brain toxic protein (tau and amyloid) accumulation. Today she will give a talk on the subject of Lewy Body Dementia, including discussion of an exciting new clinical development in the diagnosis of Lewy Body Disease: We now have available to us a skin test that can help determine this diagnosis with remarkably high sensitivity and specificity.
Department of Molecular, Cellular and Biomedical Sciences, CUNY School of Medicine, The City College of New York, New York, NY 10031, USA,
Adjunct Professor in Neurology, NYU Langone Medical Center & Comprehensive Epilepsy Center, New York, NY 10016, USA
Amyloidosis is a neurodegenerative disease: Neuromolecular Imaging the Tau Peptide LIVE with a Quantum Polymer Sensing System based on the Broderick Nanoprobe: Parkinson’s Disorders and the epilepsies
Dr. Prof. Patricia A. Broderick PhD is a Full and Tenured Medical Professor in the Department of Molecular and Cellular Science at the City University of New York Medical School, CCNY, USA. Patricia serves as CUNY Graduate Faculty in Psychology and Biology. Patricia earned her doctoral degree in Pharmacology at the St. John’s University College of Arts and Sciences where she discovered that the neurotransmitter, serotonin, has an active role in the neuronal balance of lithium therapy for bipolar illness. Patricia was then recruited by the Albert Einstein College of Medicine, Depts. Psychiatry and Neuroscience to serve as Postdoctoral Fellow and with her expertise in atomic absorption spectrophotometry and fluorescence spectroscopy, Patricia wedded behavior directly to the brain electronically and invented the BRODERICK PROBE® nanoprobe biosensor which bears her father’s name. Einstein was the first to patent her work! The work continued at Cornell Medical Center, upstate, focusing on cognition and hypoxia as Research Fellow. Then, her innovative brain/sensing research was recruited by the NYU Medical Center, Dept. Neurology and Comprehensive Epilepsy Center and Patricia was appointed as Adjunct Professor while continuing her CUNY Medical School work in tandem. Intraoperative studies of the epilepsy patient, under Institutional Review Board, approval, translated Patricia’s work to the clinic! The Dept. of Anesthesiology recruited Patricia to see inside the brain to heal postoperative memory loss. She founded the Broderick Brain Foundation and Eazysense Nanotechnologies Inc. which hold considerably valued Patents and Trademarks. Multiple editorial boards, podcasts and prolific publications are available. No stranger to the airways, Patricia serves public health as educator in the brain and electronic sciences every day. YouTube: Eazysense Nanotechnology.com@eazysense12345. Ready now, on the internet, is her new book Neuroimaging Sensing Biochemistry in the Brain. Jenny Stanford Publishing Pte. Ltd. Singapore
biosensors; chemical sensors; nanosensors; bioprobes; neuromolecular imaging (NMI); neurotransmitters; neurochemicals; in vitro; in vivo; in situ; brain; behavior; neurosystem disorders and treatment
Invited Speakers
School of Rehabilitation, Faculty of Medicine, University of Montreal and Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR), Institut universitaire sur la réadaptation en déficience physique de Montréal (IURDPM), Montréal, QC, Canada
Program ENSEMBLE!- Training with innovative technologies based on rehabilitation research: challenges and opportunities for patients, clinicians and researchers
Professor Dahlia Kairy is full professor at the School of Rehabilitation of the Université de Montréal in the physiotherapy program and researcher at the CRIR (Centre for Interdisciplinary Research in Rehabilitation of Metropolitan Montreal) at the site of the Institut universitaire sur la réadaptation en déficience physique de Montréal. She was appointed in 2021 to the Royal Society of Canada in the College of New Scholars, Artists and Scientists. A physiotherapist by training, she is interested in the development and evaluation of rehabilitation technologies, including technologies for telerehabilitation and virtual care. She is particularly interested in integrating the perspective of all users in the development and implementation of these technologies. Her expertise also includes implementation science and developing strategies to understand and facilitate the adoption of new practices in clinical practice.
Technology, physical rehabilitation, training, dose
School of Rehabilitation, Faculty of Medicine, University of Montreal and Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR), Institut universitaire sur la réadaptation en déficience physique de Montréal (IURDPM), Montréal, QC, Canada
Program ENSEMBLE!- Training with innovative technologies based on rehabilitation research: challenges and opportunities for patients, clinicians and researchers
Sylvie Nadeau, PT, Ph.D., is a full professor at the School of Rehabilitation and a past Director (2015-2021) of the Physical Therapy Programs at the University of Montreal (Canada). She is a senior researcher at the Centre for Interdisciplinary Research in Rehabilitation (CRIR) in Montreal. She obtained a MSc as well as a PhD in biomedical sciences (rehabilitation curriculum) from the University of Montreal in 1993 and 1997, respectively. Afterwards, she completed three postdoctoral trainings, one at the Laboratory of Neurobiology and Movement in Marseille, one at the School of Rehabilitation therapy of Queen’s University in Kingston, Ontario and one at l’Institut de réadaptation en déficience physique de Québec. Her areas of interest include kinesiological biomechanics, gait and other functional task analysis, dynamometry and understanding of factors limiting functional performance in healthy, orthopedic and neurological patient populations. She is also interested in developing new interventions and outcomes in rehabilitation. Professor Nadeau has more than 171 papers published and has given more than 50 invited lectures. She is a member of the Canadian and Quebec Physical Therapy Association, the Canadian Society of Biomechanics, the Quebec Interactive technologies of engineering in rehabilitation strategic network. Professor Nadeau is an Associate Editor for the Annals of Physical Rehabilitation Medicine since October 2017.
Technology, physical rehabilitation, training, dose
Department of Physical Therapy, AdventHealth University – Orlando-FL
Challenges for implementing the Parkinson’s disease clinical practice guideline
Dr. Swarowsky earned her bachelor’s in physical therapy at the Lutheran University of Brazil in 2000. She also earned a master’s and Ph.D. in Neuroscience from the Federal University of Rio Grande do Sul – Brazil. She completed two post-doctoral fellowships, one in Neuroscience (in Brazil) and the other in Motor Control at the University of Miami – Miller School of Medicine. While in Brazil, she was an Associate Professor at the Physical Therapy Department at Santa Catarina State University from 2010 to 2019, where she coordinated a community-based program for people with Parkinson’s disease and mentored several research projects. From 2019 to 2021, Dr. Swarowsky was an Associate professor in the DPT Program at the University of Jamestown (North Dakota). She obtained her Florida PT license in 2022. She is also a member of several associations, such as ANPT/APTA, ABRAFIN, and INPA. Her area of expertise is Neurological Rehabilitation, especially movement disorders and movement analysis. Dr. Swarowsky has published several manuscripts in peer-reviewed journals, and her primary research interest is Parkinson’s disease.
Parkinson’s disease, implementation, evidence-based practice
Brain Stimulation Guided by Neuroimaging to Improve Memory
Professor Vincent P. Clark received his PhD in Neuroscience from UCSD and received his postdoctoral training at NIMH. He moved to New Mexico in 2002, and was Scientific Director of the Mind Research Network before becoming Founding Director of the Psychology Clinical Neuroscience Center, and is currently Professor of Psychology and Neuroscience at the University of New Mexico. His research focuses on combining neuroimaging and neuromodulation to study cognition and to enhance healthy cognition and to treat brain and mental illness. He employs a combination of neuroimaging (MRI, EEG, MEG, fNIRS) and neuromodulation (TES, TMS, TUS, tPBM, CLAS and others) techniques to increase learning and memory in healthy people, and to study and treat clinical disorders such as dementia, addiction, schizophrenia, chronic pain and others. He is Founding Chair of the Brain Stimulation and Imaging Meeting (BrainSTIM), which has previously met in Honolulu, Geneva, Vancouver, Singapore, Rome, and Helsinki.
Neuroimaging, fMRI, neuromodulation, tDCS, TUS, memory, learning
Olfactory Impairment as predictor of REM Sleep Behavior Disorder (RBD) in Parkinson's Disease
Prof Paolo Solla is an associate professor at the University of Sassari, Department of Medicine, Surgery and Pharmacy, Italy. His research focused on neurodegenerative diseases and movement disorders. His study is focused on gender differences in motor and non-motor symptoms of Parkinson's disease patients with preeminent interesting on behavioral, neuropsychiatric and cardiovascular disorders. Recently, Prof Solla published different studies on olfactory impairment in Parkinson's disease in association to cognitive decline in Parkinson's disease patients. Prof Solla worked as author and co-author of more of 100 publications.
Neurological disorders, Parkinson’s disease, Parkinsonism and Related Disorders
Registration
The registration for IECBS 2024 will be free of charge! The registration includes attendance to all conference sessions.
When registering with several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 20 October 2024.
Instructions for Authors
The 4th International Electronic Conference on Brain Sciences will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
Important Deadlines
Deadline for abstract submission: 25 June 2024 23 July 2024.
Announcement of oral and poster abstract results: 26 July 2024 23 August 2024.. You will be notified of the acceptance of an oral/poster presentation in a separate email.
Abstract Submission
Abstract submissions should be completed online by registering with www.sciforum.net and using the "New Submission" function once logged into the system. No physical template is necessary.
1. The structure abstract should include the introduction, methods, results, and conclusions sections of about 200–250 words in length.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Oral Presentation and Slides Submission
The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the abstract. Slides, if available, will be displayed directly on the website using the proprietary slide viewer at Sciforum.net. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format prior to submission so that they can be converted for online display.
- Your submission should include the title, authors, contact details and main research findings, as well as tables, figures, and graphs where necessary.
- File format: PDF (.pdf).
- Size in pixel: 1,080 width x 1,536 height–portrait orientation.
- Size in cm: 60 width x 80 height–portrait orientation.
- Font size: ≥20.
- Maximum size: 250 M
You can use our free template to create your poster. The poster template can be downloaded here.
Step 1 https://sciforum.net/dashboard/author/submissions
Step 2 Choose the correct conference and submission id, click upload button
Step 3 Upload poster (not oral presentation slides) and click submit button
Copyright
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunity
1. Brain Sciences Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the Special Issue published in Brain Sciences (ISSN: 2076-3425, IF 2.7), with a 20% discount on the publication fee. Special Issue information: "Selected Papers from the 4th International Electronic Conference on Brain Sciences" (https://www.mdpi.com/journal/brainsci/special_issues/1J47XZ11CO). All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
Please note if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers.
2. Proceeding Paper Publication
All accepted abstracts will be published in the conference report of The 4th International Electronic Conference on Brain Sciences in the Biology and Life Sciences Forum (ISSN: 2673-9976), if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference. Publication of the proceedings will be free of charge.
Authors are asked to disclose that it is a proceeding paper of the IECBS 2024 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings paper submission deadline: 11 December 2024.
Manuscripts for the proceedings issue must be formatted as follows:
- Title.
- Full author names.
- Affiliations (including full postal address) and authors' e-mail addresses.
- Abstract.
- Keywords.
- Introduction.
- Methods.
- Results and Discussion.
- Conclusions.
- Acknowledgements.
- References.
List of accepted submissions (76)
Id | Title | Authors | |||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sciforum-101451 | Sex differences in hippocampal learning and induced plasticity at CA1 synapses in infancy | , , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Introduction: We previously reported sex differences in the developmental trajectories of contextual learning function and found multiple critical periods for hippocampal function in male rats. Here, we focus on training-induced hippocampal CA1 synaptic plasticity in early childhood to analyze sex differences. Methods: Male (n = 27) and female (n = 18) rats at 16-17 days of postnatal age were subjected to a hippocampal-dependent inhibitory avoidance (IA) task. CA1 neurons received inputs from CA3 and the entorhinal cortex (EC) via different synaptic pathways. Brain slices were then analyzed to assess CA1 synaptic plasticity, focusing on changes in the ratio of AMPA receptor- / NMDA receptor-mediated postsynaptic currents, and single-vesicle-induced miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs). Behavioral battery tests evaluated sensory, motor, and emotional functions. Results: IA learning was established in females (P < 0.01) but not in males, indicating sex differences in contextual learning ability without changes in basic sensory/motor functions. In the emotional state, females showed more sociability with others than males (P < 0.05). Frequency of mEPSCs and mIPSCs decreased in males after learning (P < 0.01), whereas mIPSCs frequency increased in females (P < 0.05). Furthermore, AMPA/NMDA ratios increased in the CA3-CA1 and ECIII-CA1 pathways after learning, suggesting a predominance of AMPA receptor-mediated synaptic plasticity after learning (P < 0.01). Unpaired t-tests were used to analyze the results. Conclusion: Female infants showed faster development of hippocampal learning and induced plasticity than male infants, indicating a clear sex difference. These findings provide synaptic evidence for sex-specific development of contextual learning and training-induced plasticity at CA1 synapses. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-101846 | Ecological Assessment of Executive Functions in Grocery Shopping: A Pilot Study for ABI Training | , , , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Introduction: Acquired brain injury (ABI) can significantly impair executive functions (EFs), which are essential for controlling and regulating actions. This impairment makes everyday tasks, such as grocery shopping, particularly challenging for individuals with ABI. This study aims to conduct a pilot investigation to analyze the shopping strategies of control individuals without ABI. The objective is to adapt this ecological assessment method for individuals with ABI and design an EF training program. Method: For the pilot study, 16 subjects were recruited through word-of-mouth and social networks. The sample included men and women aged 18 to 65 years without brain damage or neurological pathologies. Two tools were implemented to register participant performance. A supermarket plan was uploaded to the Samsung photo editor, where participants' routes were mapped, providing graphical information about their performance. A list of products was created on Notion to record which products were collected and when, facilitating detailed analysis of participant performance during the shopping task. Results: The mean and standard deviation of section entries (M=1.42, SD=0.5), products acquired (M=12.9, SD=3), and total shopping time (M=16.11, SD=4) were obtained. The use of these tools enabled precise tracking of participant actions, confirming the feasibility of the method. Conclusions: The method of ecologically evaluating EF and shopping strategies, supported by these tools, is feasible and provides valid information for cognitive skills training in ABI individuals. This pilot study offers promising results for future interventions. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-098676 | Methods for estimating the similarity of contours of gray matter in mammalian spinal cord transverse sections |
,
,
Aleksandr Veshchitskii ,
|
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Subject of study: We focused on images of transverse sections of the mammalian spinal cord belonging to its various segments. Aim of study: We selected optimal methods for assessing the similarity of images of transverse sections of the spinal cord obtained earlier in different histological studies. Method: We assessed the similarity of images of transverse sections of the spinal cord with the help of (a) Jaccard index (the size of the contour's intersection divided by the size of the contour's union), (b) metrics of distance between gray matter contours, (c) correlations between gray matter contours, and (d) the difference between gray matter contours based on Hu moments (a set of seven numbers calculated using central moments that are invariant to image transformations). Main results: Jaccard index and metrics of distances between contours allowed us to successfully determine the degree of similarity of sections obtained from the same animal. Hu invariant moments are suitable for the successful recognition of images of spinal cord segments obtained from various sources. Practical significance: The results suggest that the automated identification of spinal cord segments can be based on a comparison of histological or tomographic images of transverse sections of the spinal cord with some databases containing a set of reference images of particular segments. Such comparisons may be performed with the help of the contour similarity methods based on the Hu invariant moments. This work was supported by the Russian Science Foundation, project №21-15-00235. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-085405 | Applications of terbium halide-filled single-walled carbon nanotubes in biomedicine |
Show Abstract |
|||||||||||||||||||||||||||||||||||||||
Terbium halides are interesting compounds that are incorporated inside single-walled carbon nanotubes (SWCNTs). Bioimaging with terbium halide-filled SWCNTs is a very promising field. For applications in bioimaging, it is important to investigate the filling ratio and the yield of the preparation processes of the nanocomposites. The synthesis of filled SWCNTs is a chemical process involving melted substances. The melted terbium chloride (TbCl3), terbium bromide (TbBr3), and terbium iodide (TbI3) are introduced into the SWCNTs in a high-temperature process. This results in the preparation of the compound-containing nanocomposites. The chemical properties of the filled SWCNTs are investigated with transmission electron microscopy (TEM) and spectroscopy. The TEM shows very interesting incorporated compounds. The p-doping of SWCNTs is investigated in the filled SWCNTs. The interesting properties that accompany these nanocomposites may find applications in nanobiotechnology and bioimaging. In this contribution, we synthesize the terbium halide-filled SWCNTs with melted compounds. We incorporate the substances into the SWCNTs in the high-yield process. The filling ratios of the SWCNTs are very large, as revealed with the TEM. The interesting microstructures of the compounds are found in the TEM images. We demonstrate this with micrographs of the filled SWCNTs. In the terbium halide-filled SWCNTs, the p-doping of SWCNTs is revealed with spectroscopy as modifications of Raman modes. Shifts and intensity variations are observed with the spectra. Therefore, the interesting rare-earth compounds inside SWCNTs form a perspective platform for nanobiotechology, and the bioimaging of cells, tissues, and organs. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-086522 | The effect of silicic acid and alcoholic beer intake on the excretion of chromium and vanadium and their deposition in the brains of mice chronically exposed to aluminium nitrate |
,
,
Mark Evans ,
,
María José González-Muñoz ,
,
|
Show Abstract |
||||||||||||||||||||||||||||||||||||||
The effect of aluminium (Al) exposure and silicon (Si) intake on the levels of chromium (Cr) and vanadium (V) in mouse brains was studied. Six-week-old male NMRI mice were divided into four groups. Three groups received Al(NO3)3 at a dose of 450 μg/ml for three months; meanwhile, the fourth group only received deionised water. The first group received aluminium nitrate (Al group); the second group aluminium nitrate and silicic acid (50 mg/ml); and the third group aluminium nitrate and commercial beer. Metals were monitored by ICP-OES in the right hemibrain, faeces, urine and blood. V was only detected in the faecal samples, being significantly higher in the Al group (4.132 vs. 3.383, 3.100 and 3.315; groups 4, 2 and 3, respectively; all in μg/g; p-value=0.038). Conversely, lower and significantly lower levels of Cr were detected in the faeces (2.867 vs. 3.155, 2.270 and 2.550 μg/g; p-value=0.296) and blood (0.187 vs. 0.158, 0.197 and 0.211 μg/l; p-value=0.013) in the Al group, respectively, as well as in the urine (0.00047 vs. 0.00069, 0.00060, 0.00065 μg/μmol creatinine; p-value=0.311), suggesting a potential effect of Al intoxication on the metabolism of Cr. These unknown effects might explain the lower levels of Cr that were detected in the intoxicated animals’ brains (0.346 μg/g). Thus, the intoxicated animals that were provided with Si showed Cr brain levels slightly higher than those in the Al group (0.360 and 0.352 vs. 0.346 μg/g; p-value=0.552). The consumption of beer/silicic acid appears to partially block the negative effects of aluminium ingestion on the normal metabolism of chromium. |
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide 6 awards including Best Oral Presentation Award and Best Poster Award.
The Awards
Number of Awards Available: 6
The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be six winners selected for this award. The winner will receive a certificate and 200 CHF each.
Sponsors and Partners
For information regarding sponsorship and exhibition opportunities, please click here.
Organizers
Media Partners
Conference Secretariat
Ms. Aria Chen
Ms. Jasmine Li
Ms. Wong Jolin
Ms. Skyler Wu
Email: iecbs2024@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
S1. Behavioral Neuroscience
Behavioral neuroscience is an interdisciplinary field that investigates the complex interplay between brain function and behavior, drawing upon insights from various key research areas. By integrating methodologies from neurobiology, neurophysiology, neuropharmacology, neuroimaging, and cognitive neuroscience, it investigates the intricate underlying mechanisms. We encourage global neuroscientists and doctors to discuss the integrative endeavors to hold significant implications for understanding neurological disorders, thereby contributing to the advancement of further therapeutic interventions.
Keywords: neurobiology; neurophysiology; neuropharmacology; neuroimaging; cognitive neuroscience; behavioral neurology; neuroinformatics
Session Chair
Assoc. Prof. Dr. Woon-Man Kung, Division of Neurosurgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23412, Taiwan;, Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University, Taipei 11114, Taiwan
Show all published submissions (9) Hide published submissions (9)
Submissions
List of Papers (9) Toggle list
S2. Systems Neuroscience
The rapidly growing body of literature in the field of neuroscience underscores the importance of interdisciplinary and inter-subject collaboration. The concept of system neuroscience focuses on going beyond the individual neuroscience domains and toward more general neuroscience concepts. At the session, we will discuss submissions on various topics that address systematic issues in today's neuroscience research.
Keywords: neuroscience integration; interdisciplinary research; system-wide approach
Session Chair
Prof. Dr. Konstantin V. Slavin, Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA
Show all published submissions (5) Hide published submissions (5)
Submissions
List of Papers (5) Toggle list
S3. Neurotechnology and Neuroimaging
Over the last few decades, technological advances have resulted in earlier and more accurate diagnosis and successful therapeutic intervention of neurological disorders. Advanced multimodal neuroimaging and OCT not only solve diagnostic challenges but also provide helpful biomarkers to monitor disease progression. Newly approved drugs and therapeutic interventions, such as transcranial magnetic and vagal nerve stimulation have offered new hope to people with non-curable neurological diseases. In this session, we welcome posters and manuscripts addressing diagnostic and therapeutic technological advances in Neurology.
Keywords: magnetic resonance imaging; positron emission tomography; neurodegeneration; nanotechnology; optical coherence tomography
Session Chair
Dr. Evanthia Bernitsas, Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, MI 48201, USA
Show all published submissions (13) Hide published submissions (13)
Submissions
List of Papers (13) Toggle list
S4. Neuropsychology
Neuropsychology aims to investigate the cognitive processes of the mind in relation to brain structures. Areas of interest include sensorimotor functions, perception, attention, spatial construction, intelligence, executive functions, memory, language, motivation, emotions, and quality of life. Historically, it has developed with the study of adult patients with brain injury of different origins. Over the years, the spectrum of investigation has broadened to the study of developmental lesions and children with language and learning disorders. The increasing availability of neuroimaging techniques and, even more recently, of neurostimulation techniques has made a fundamental contribution to the growth of current knowledge and has definitively pointed to the discipline as a multidisciplinary area of convergence among numerous skills and professions. In this multidisciplinary perspective, the session aims to bring together recent updates in neuropsychological research. Presentations that focus on neuropsychological function in both healthy and disordered conditions and across the lifespan are encouraged. Submissions that address the development and testing of neuropsychological interventions are also encouraged.
Keywords: attention deficits; neglect; language disorders; learning disabilities; stroke; traumatic brain injury; neurostimulation; neuropsychological rehabilitation
Session Chair
Prof. Dr. Pierluigi Zoccolotti, Department of Psychology, Sapienza University of Rome, 00185 Rome, Italy
Show all published submissions (4) Hide published submissions (4)
Submissions
List of Papers (4) Toggle list
S5. Neurodegenerative Diseases
Olfactory dysfunction in neurodegenerative diseases
Different neurodegenerative diseases are associated with olfactory impairment. The degree of olfactory dysfunction may vary among different neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, and progressive supranuclear palsy. In particular, in Parkinson’s disease, the olfactory deficits may precede the occurrence of motor symptoms; they are, therefore, often underestimated in patients during the early stages of the disease.
The aim of this specific section is to correlate olfactory dysfunction with neurodegenerative diseases, in order to evaluate the progression of pathology and the quality of life in patients.
Keywords: olfactory dysfunction, neurodegenerative diseases, Alzheimer’s disease, Parkinson’s disease.
Session Chair
Assoc. Prof. Carla Masala, Department of Biomedical Sciences, University of Cagliari, SP 8 Cittadella Universitaria, 09042 Monserrato, Italy
Show all published submissions (11) Hide published submissions (11)
Submissions
List of Papers (11) Toggle list
S6. Cognitive Neuroscience
The session endeavors to understand how the mind works. Trying to understand our minds is perhaps the most ambitious and exciting project in all of science, and this project requires tools drawn from fields that include experimental psychology, artificial intelligence and computer science, linguistics, vision science, philosophy, anthropology, behavioral economics, and neuroscience (among others). This session will introduce the most recently developed tools and theories from these areas, as they relate to the study of the mind. We will explore the latest advances in mental processes such as perception, reasoning, memory, attention, imagery, language, intelligence, decision making, morality, and even attraction and love, as well as the technologies and findings that support the effective study of applications in learning, health, rehabilitation, decision making, strategic thinking, international affairs, human development, and in human factors. In sum, this session will examine the assumptions of cognitive science and many of the most important and fascinating results obtained of late to gain important new insights into what we are and how we work!
Key words: cognitive neuroscience; developmental science; cognition; learning; perception; artificial intelligence; perception; decision making; aging
Session Chair
Prof. Dr. Gerry Leisman, Movement and Cognition Laboratory, Faculty of Social Welfare and Health Sciences Haifa University, Haifa, Israel, Department of Clinical Neurophysiology, Institute for Neurology and Neurosurgery, University of the Medical Sciences of Havana, Havana, Cuba
Show all published submissions (8) Hide published submissions (8)
Submissions
List of Papers (8) Toggle list
S7. Clinical Neuroscience
Findings from basic neuroscience research continue to promote the advancement of clinical neuroscience. This session reviews new findings from translational neuroscience that can help to improve the diagnosis and treatment of neurologic, psychiatric and neuropsychiatric disorders.
Keywords: clinical neuroscience; translational medicine; neurologic disorders; neuropsychiatric disorders
Session Chairs
Dr. Robert Emmett Kelly, Clinical Psychiatry, Weill Cornell Medical College, White Plains, NY 10605, USA
Dr. med. Dejan B. Budimirovic, Department of Psychiatry, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD 21205, USA, Department of Psychiatry & Behavioral Sciences-Child Psychiatry, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
Show all published submissions (4) Hide published submissions (4)
Submissions
List of Papers (4) Toggle list
S8. Molecular and Cellular Neuroscience
Molecular and Cellular Neuroscience invites leading scientists, physicians, practitioners, and scholars to discuss positive and inspiring perspectives on the theragnostics of brain, spinal, and cellular disorders at the microscopic level. Advancing diagnostics and therapeutics where the molecule and cell meet is especially unique at the DNA, mRNA, chromosomal, and genetic frontiers, and tools such as CRISPR can mobilize the questioning brain toward success in patients and animal models. Stroke victims, the triple threat of Alzheimer’s, Parkinson’s, and epilepsies, and degeneration as well as autistic reverse neurodegeneration propel us toward recovery for life at its best. Advances in reverse aging oblige us to engage in molecular and neuromolecular tools to defray substance use disorders that may propel aging. While we carefully tread into Newtonian Einstein mechanics to ensure health at the atomic and subatomic levels, the question “Can Tau be solved with quantum mechanics?” may be asked.
Keywords: psyche; mind; neurology; psychology; surgery; diagnostics; therapeutics; cell biology; signaling pathways; mental disorders; neuroinflammation; the immune system; interleukins; cytokines; dermatology; cell metabolism; cancer; stress; movement disorders; Lewy body disease; cognition; amyloids; multiple system atrophy; addiction; quantum gravity; sensors; drug delivery; molecular biology; pharmaceutical industry; biomedical industry.
Session Chairs
Prof. Dr. Patricia A. Broderick, Department of Molecular, Cellular and Biomedical Sciences, CUNY School of Medicine, The City College of New York, New York, NY 10031, USA
Dr. Stefano Casalotti, School of Health Sport and Bioscience, University of East London, London, UK
Show all published submissions (14) Hide published submissions (14)
Submissions
List of Papers (14) Toggle list
S9. Neurorehabilitation
Neurological diseases often are associated with long-term disabilities, poor quality of life, and worse self-rated health. Recent advances have been observed in the understanding of the disability process, including the role of contextual factors in improving clinical decision making in the neurorehabilitation field. This session calls for contributions related to therapeutic approaches in rehabilitation aimed at recovering function and health, preventing disability and disease-associated risk factors, and promoting function and health in people with neurological disease. In particular, contributions devoted to improving evidence-based practice in clinical decision making in neurorehabilitation are welcomed.
Keywords: neurorehabilitation; function; disability; quality of life; clinical decision making; evidence-based practice
Session Chair
Prof. Dr. Christina Danielli Coelho De Morais Faria, Department of Physical Therapy, Universidade Federal de Minas Gerais, Brazil
Show all published submissions (8) Hide published submissions (8)
Submissions
List of Papers (8) Toggle list